MA LEK AM Maciejowscy SC Centrum Terapii SM

Katowice 40-595

1 studies enrolling now · 6 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis Spasticity, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorder, Partial Epilepsy, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity — Recruiting now
• A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis — Running, not enrolling
• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed